1. Home
  2. AURA vs SAR Comparison

AURA vs SAR Comparison

Compare AURA & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • SAR
  • Stock Information
  • Founded
  • AURA 2007
  • SAR 2007
  • Country
  • AURA United States
  • SAR United States
  • Employees
  • AURA N/A
  • SAR N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • SAR Investment Managers
  • Sector
  • AURA Health Care
  • SAR Finance
  • Exchange
  • AURA Nasdaq
  • SAR Nasdaq
  • Market Cap
  • AURA 396.8M
  • SAR 402.9M
  • IPO Year
  • AURA 2021
  • SAR 2007
  • Fundamental
  • Price
  • AURA $6.57
  • SAR $24.65
  • Analyst Decision
  • AURA Strong Buy
  • SAR Hold
  • Analyst Count
  • AURA 7
  • SAR 5
  • Target Price
  • AURA $22.29
  • SAR $24.56
  • AVG Volume (30 Days)
  • AURA 139.6K
  • SAR 106.2K
  • Earning Date
  • AURA 08-13-2025
  • SAR 10-07-2025
  • Dividend Yield
  • AURA N/A
  • SAR 12.10%
  • EPS Growth
  • AURA N/A
  • SAR 105.87
  • EPS
  • AURA N/A
  • SAR 2.47
  • Revenue
  • AURA N/A
  • SAR $142,495,705.00
  • Revenue This Year
  • AURA N/A
  • SAR N/A
  • Revenue Next Year
  • AURA N/A
  • SAR $1.97
  • P/E Ratio
  • AURA N/A
  • SAR $10.03
  • Revenue Growth
  • AURA N/A
  • SAR N/A
  • 52 Week Low
  • AURA $4.35
  • SAR $21.10
  • 52 Week High
  • AURA $12.38
  • SAR $26.49
  • Technical
  • Relative Strength Index (RSI)
  • AURA 50.72
  • SAR 38.56
  • Support Level
  • AURA $6.20
  • SAR $25.41
  • Resistance Level
  • AURA $6.80
  • SAR $25.64
  • Average True Range (ATR)
  • AURA 0.29
  • SAR 0.27
  • MACD
  • AURA -0.00
  • SAR -0.10
  • Stochastic Oscillator
  • AURA 67.14
  • SAR 9.55

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: